Company intelligence / Profile preview

BTT Group

Ownership: Private
Development stage: Preclinical

Overview

BTT Group, through its core companies such as Biotoxtech, Keyprime Research, and Keyfron Bio, provides GLP-certified preclinical toxicology and bioanalytical services to global pharmaceutical and biotech clients. The group supports drug development by conducting safety and efficacy studies for next-generation biologics and innovative therapeutics.

Modalities: AntibodyProteinGene therapy
Industry: Contract Research Organization

Beyond the preview

Go deeper on BTT Group.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on BTT Group.

Explore the full profile